Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06275685 · ClinicalTrials.gov registry record · NA
Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
A NA study of Epilepsy; Seizure, sponsored by Empatica.
- Recruiting
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 1
- Study location
NCT06275685 is a NA study of Epilepsy; Seizure that is actively recruiting participants, run by Empatica. The registered enrollment target is 3,000 participants, above the 36-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (8233% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06275685, a NA study of Epilepsy; Seizure, is actively recruiting participants, sponsored by Empatica.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional study is to develop a personalized seizure risk forecast tool in people with epilepsy. The main questions it aims to answer are: * can we develop a future seizure probabilities tool that is more accurate than chance based on the pattern and frequency of previous generalized tonic-clonic seizure (GTCS) events, as well as changes in physiological and behavioral variables. * does this tool improve the lives of people with epilepsy? Researchers will compare a group that does not have access to the forecast tool to a group that does and see if it is accurate and if people with it report that it improved their quality of life.
Conditions Studied
Interventions
- DEVICE SeizureWise algorithm
- DEVICE Multi-day Visualizations
Study Locations (1)
Massachusetts
- Empatica - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2024-04-11 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06275685
The ClinicalTrials.gov registry entry for NCT06275685 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 36-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (8233% higher). The listed sponsor is Empatica, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epilepsy; Seizure appearing as the primary indexed condition, and to 2 interventions - of which SeizureWise algorithm is the first listed.
NCT06275685 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06275685 about?
NCT06275685 is a clinical study titled "Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking". The goal of this interventional study is to develop a personalized seizure risk forecast tool in people with epilepsy. The main questions it aims to answer are: * can we develop a future seizure probabilities tool that is more accurate than chance based on the pattern and frequency of previous gen...
What is the current status of trial NCT06275685?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2024-04-11. Estimated completion is 2026-06.
What conditions does trial NCT06275685 study?
This clinical trial studies the following conditions: Epilepsy; Seizure.
What interventions are being tested in trial NCT06275685?
The interventions under investigation include: SeizureWise algorithm (DEVICE), Multi-day Visualizations (DEVICE).
Who is sponsoring clinical trial NCT06275685?
This trial is sponsored by Empatica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06275685 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy; Seizure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Brain Stimulation Parameters
RECRUITING · NA
-
Thalamus Seizure Detection With a Deep Brain Stimulator System
RECRUITING · NA
-
Sleep Spindles and Memory in Rolandic Epilepsy
RECRUITING · NA
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.